Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) CEO Sean Bohen sold 52,328 shares of the stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $9.37, for a total value of $490,313.36. Following the sale, the chief executive officer now owns 298,836 shares in the […]

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) CEO Jay R. Luly sold 5,142 shares of Enanta Pharmaceuticals stock in a transaction dated Friday, December 6th. The stock was sold at an average price of $8.06, for a total transaction of $41,444.52. Following the completion of the transaction, the chief executive officer now directly owns […]